
Organization · Venture Capital
IMPETUS Capital
IMPETUS Capital is an early-stage venture capital firm based in Sofia, Bulgaria, focusing on rapidly growing tech companies in Emerging Europe, particularly those with ties to Bulgaria and Romania.
Overview
What IMPETUS Capital does
What IMPETUS Capital is
IMPETUS Capital is an early-stage venture capital firm based in Sofia, Bulgaria, focusing on rapidly growing tech companies in Emerging Europe, particularly those with ties to Bulgaria and Romania.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2015
- Approximate age
- About 11 years
- Structured capabilities
- Funder
- Last reviewed
- April 26, 2026
Official channels
Find IMPETUS Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
IMPETUS Capital as a funder
Investment thesis
IMPETUS backs exceptional founder-led technology companies from Emerging Europe that are growing rapidly and can expand globally. The firm focuses on connecting private-company execution with public-market financing routes, including pre-IPO and IPO support.
Focus narrative
IMPETUS Capital invests in early growth and pre-IPO companies, structuring deals that extend through to exit windows. The organization primarily targets companies founded by Emerging European teams, with a preference for those with a Bulgarian or Romanian connection. The firm emphasizes growth, capital-market readiness, and governance in its investment approach.
Value beyond capital
IMPETUS Capital provides value to its portfolio companies by connecting them with private capital and guiding them through public-market financing routes. The firm emphasizes long-term active ownership, governance, and capital-market readiness, helping companies navigate their growth and exit strategies effectively.
Terms and economics
- Typical check
- $300,000–$1,500,000
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series A+ · Series B · Series B+ · Series C · Series C+ · Series D · Series E · Growth Equity · Pre-IPO · Ipo
- Sectors
- Artificial IntelligenceSaaS & Cloud SoftwareBiotech & Life SciencesHealthcareFintechCybersecurityLogistics & Supply ChainEnergyClimate & SustainabilityConsumer
- Regions
- Europe
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 17
- Recorded notable exits
- Shelly Group and Hydrogenera
Portfolio context
Notable portfolio companies include: A4E: AI-powered SME forecasting and automation. BIODIT: Biometric security solutions. DAYE: Innovative gynecological health platform. HYDROGENERA: Green hydrogen company, recently IPOed. GLYCANAGE: Biological age testing company, committed $550k in a $5m round. SHELLY GROUP: IoT & Smart home solutions, backed and later IPOed by IMPETUS.
Connected ecosystem
Continue from IMPETUS Capital
These links use structured organization type, sector, and regional relationships. They do not imply endorsement or commercial similarity.
Same organization type
Structured sector focus
Structured regional focus
Common questions
What to know about IMPETUS Capital
Upseed classifies IMPETUS Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 26, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.